For: | Brayette A, Essig M, Carrier P, Debette-Gratien M, Labrunie A, Alain S, Maynard M, Ganne-Carrié N, Nguyen-Khac E, Pinet P, De Ledinghen V, Renou C, Mathurin P, Vanlemmens C, Di Martino V, Gervais A, Foucher J, Isabelle FH, Vergniol J, Hourmand-Ollivier I, Cohen D, Duval X, Poynard T, Bardou M, Abergel A, Dao MT, Thévenot T, Hiriart JB, Canva V, Lassailly G, Aurières C, Boyer N, Thabut D, Bernard PH, Schnee M, Larrey D, Hanslik B, Hommel S, Jacques J, Loustaud-Ratti V. Subclinical proximal tubulopathy in hepatitis B: The roles of nucleot(s)ide analogue treatment and the hepatitis B virus. World J Hepatol 2020; 12(12): 1326-1340 [PMID: PMC7772739 DOI: 10.4254/wjh.v12.i12.1326] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v12/i12/1326.htm |
Number | Citing Articles |
1 |
Chiara Masetti, Nicola Pugliese, Alessio Aghemo, Mauro Viganò. Safety of current antiviral drugs for chronic hepatitis B. Expert Opinion on Drug Safety 2022; 21(7): 939 doi: 10.1080/14740338.2022.2045271
|
2 |
Andinet Gizaw, Wendy C. King, Amanda S. Hinerman, Raymond T. Chung, Mauricio Lisker‐Melman, Marc G. Ghany, Mandana Khalili, Mamta K. Jain, Jacob Graham, Theresa Swift‐Scanlan, David E. Kleiner, Mark Sulkowski, David K. Wong, Richard K. Sterling. A prospective cohort study of renal function and bone turnover in adults with hepatitis B virus (HBV)‐HIV co‐infection with high prevalence of tenofovir‐based antiretroviral therapy use. HIV Medicine 2023; 24(1): 55 doi: 10.1111/hiv.13322
|